Copper-doped zinc oxide nanoparticles as efficient antimicrobial agents: bridging electronic properties with biological properties Authors: Sultan Saad Almadhhi, Anuj Kumar, Mohd Ubaidullah, Kholnazarov Bakhodir Azamovich, Toshkulov A Kh, Aziz Baxtiyorovich Ibragimov, Abdullah M Al-Enizi Published: 2026 ABSTRACT AbstractZinc oxide nanoparticles (ZnO NPs) have already shown potential applications as antimicrobial agents. However, the large band gap and charge carrier recombination of ZnO NPs reduce the production of reactive oxygen species, which limits their antibacterial activity; therefore, further modifications of their structural and electronic properties are required. Herein, Cu doping of ZnO NPs has been carried out by a microwave-assisted method to modify their structural, electronic, and biological properties. The structural and morphological analysis of the prepared Cu-doped ZnO NPs confirmed that Cu is well incorporated into the ZnO NPs lattice, and the morphology is quasi-spherical with a diameter range of 20–25 nm. The changes in the band gap and defect states in ZnO NPs, formed upon Cu doping, were confirmed by UV-visible and theoretical analysis. The antimicrobial potential of ZnO and Cu-doped ZnO NPs against S. aureus, E. coli, P. aeruginosa, and C. albicans has been evaluated by measuring the zone of inhibition, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). The results showed an enhancement of the antimicrobial potential of ZnO NPs upon Cu doping, which could be related to modifications of the electronic structure that could potentially affect redox properties.Supplementary InformationThe online version contains supplementary material available at 10.1186/s11671-026-04590-x.Keywords: Antimicrobial activity, Biological applications, Cu-doped ZnO nanoparticles, Drug delivery, Microwave-assisted synthesis Introduction In the 21st century, antimicrobial resistance has become one of the most important problems in healthcare everywhere [1]. Conventional antibiotics are being rendered ineffective against multi-drug resistant pathogens, so alternative treatments using different means to kill microbes (other than traditional antimicrobial mechanisms) must be found. In addition, the increasing need for sophisticated antimicrobial agents is highlighted by the multiplicity of infections in hospitals and in the community caused by microorganisms such as S. aureus, E. coli, P. aeruginosa, C. albicans, etc. These microorganisms are often found in wound infections, pneumonia, bacteremia and complications associated with implanted devices and particularly affect the immune-compromised patient [2, 3]. There has been an increase in the amount of resistant strains to β-lactams, cephalosporins, carbapenems, and other commonly used antibiotics creating a pressing need for the development of antimicrobial agents that are both non-antibiotic and unable to create any type of resistance but still safe and scalable [3]. In this context, nanotechnology represents an innovative approach to making new materials with unique physical and chemical characteristics that cannot be found in bulk materials [4]. As such, nano-particle materials will be able to kill microbial pathogens through various means (i.e., oxidative, ionic, disrupting cellular membranes) due to the unique properties of nano-materials such as very large surface area for their volume, tunable electronic properties, and reactive nature via defects in their crystalline structure [5]. Among metal oxide nano-materials, zinc oxide nanoparticles (ZnO NPs) have generated much interest due to their chemical stability, low cost, environmentally friendly, and well-established compatibility with human biology [6]. ZnO NPs kill bacteria primarily through the production of reactive oxygen species (ROS), the release of zinc ions (Zn2+), and/ or through electrostatic interactions between ZnO NPs and microbial cell membranes [7]. These mechanisms all contribute to result in oxidative damage to microorganisms by inducing oxidative stress, lipid peroxidation and protein denaturation leading to rupture of cellular membranes [8]. Therefore, ZnO nanostructures have been utilized in medical devices, dressings, food packaging and antimicrobial textile applications due to the aforementioned qualities of ZnO NPs [9]. However, the use of pristine ZnO NPs does not provide sufficient bactericidal effectiveness due in part to inherent electronic limitations [10–13]. A large band gap of about 3.37 eV prevents activation primarily to the UV range with rapid recombination of electron-hole pairs produced due to the photogenerated electrons suppressing effective production of ROS [14–17], which is critically required for oxidative damage to the bacteria [10–13]. Thus, to maximize the bactericidal properties of ZnO, methods need to be developed that enhance charge separation and alter the electronic properties of the material [18]. Hence, defect engineering and transition metal atom doping have become viable candidates for the atomic level manipulation of ZnO’s electronic properties. Cu is particularly attractive as a dopant in ZnO because it has a comparable ionic radius to that of Zn2+, resulting in the ability for Cu to be substituted for Zn within the lattice of ZnO without any significant structural disruption [19, 20]. Additionally, through the introduction of Cu2+ defects, it may be possible to develop localized defect states, reduce the band gap and improve the mobility of charge carriers, thereby increasing the efficiency of ROS generation. In addition to its electronic modulation capabilities, Cu has inherent antimicrobial qualities. Cu interacts adversely with various enzymatic processes, interferes with respiratory chains and denatures proteins through its inherent properties of redox cycling. Therefore, Cu-doped ZnO NP’s are predicted to have dual synergy effects involving the ability of ZnO to induce oxidative stress and Cu to induce biochemical toxicity [10, 21–23]. The conventional synthesis of Cu-doped ZnO NPs often suffers from prolonged reaction times, non-uniform dopant distribution, uncontrolled particle growth, and high energy consumption, which can compromise structural homogeneity and reproducibility. In contrast, microwave-assisted synthesis offers rapid and volumetric heating, enhanced nucleation kinetics, improved dopant incorporation, and superior control over particle size and crystallinity, making it a highly efficient and reliable route for producing uniformly Cu-doped ZnO NPs with tailored physicochemical properties [24, 25, 26]. However, not only the composition, but also the synthesis method plays a crucial role in determining the final properties of Cu-doped ZnO NPs. The preparation approaches directly affect dopant distribution, crystallinity, particle size, and defect concentration. Conventional methods such as hydrothermal or sol–gel synthesis often require longer reaction times and may lead to uneven dopant incorporation and poor reproducibility. In contrast, microwave-assisted synthesis is a fast, energy-efficient, and environmentally friendly approach that provides uniform heating, controlled nucleation, and shorter reaction times. These advantages help in achieving better control over defects and particle size, resulting in nanomaterials with consistent physical and chemical properties and good potential for large-scale production. Considering these research gaps, the present study aims to assess and compare the antibacterial activity of pure ZnO and Cu-doped ZnO NPs synthesized using a microwave-assisted approach. The antibacterial activity assay focused on clinically relevant pathogens, including S. aureus, P. aeruginosa, E. coli, and C. albicans, to determine if Cu-doped ZnO NPs showed an enhancement in antibacterial action. In the present investigation, the application of the microwave-assisted synthetic protocol helped in the homogeneous incorporation of Cu in the ZnO lattice structure while allowing for defect state modulation at the nanoscale. This helped in effectively tuning the electronic structure of ZnO NPs. This phenomenon has been supported through band gap tuning and defect state modification in ZnO NPs. This investigation has effectively established a structure–electronic property relationship by correlating the electronic structure of ZnO NPs with their overall antimicrobial activity against various pathogens. Such a correlation between the electronic structure and overall activity against pathogens differentiates this investigation from previously reported ZnO: Cu nanocomposites for biomedical applications and hence highlights its scientific novelty. Materials and methods Materials All the chemicals, including Zn(NO3)3·6H2O, and Cu(NO3)3·6H2O, and solvents like ethanol and methanol were obtained from Fisher Scientific and were used without further purification. Live bacterial cultures, as well as mannitol salt agar and nutrient agar, were obtained from Carolina Biological Supply. Synthesis of Cu-doped ZnO nanoparticles To prepare Cu-doped ZnO NPs, 5 mL aqueous solution of 0.1 M Cu(NO3)2·3H2O was dropwise added into 50 mL aqueous solution of 0.1 M Zn(NO3)2·6H2O and mixed thoroughly, avoiding any premature precipitation at this stage of mixing. After stirring for 5 min, 25 mL of 10 mM trisodium citrate (TSC) solution was added dropwise as a stabilizing and complexing agent at room temperature. This prepared solution was transferred to the microwave synthesis reactor and irradiated at 2450 MHz, 180 °C for 10 min, which provided a method of rapid nucleation and crystalline growth. After the completed irradiation process, the solution was cooled. The nanoparticles could be separated and isolated from the solution mixture by centrifugation at 1400 rpm for 10 min. Materials remaining in the bottom precipitate were washed at least three times with ethanol to eliminate any residual ions and double-distilled water to wash away impurities. The separated precipitate was taken under the high-temperature treatment calcination for 2 h at 600 °C. The obtained dark brown Cu-doped ZnO NPs are washed using ethanol to remove any loosely bound residues from the nanoparticles’ surface. This process, however, also leaves some ethanol residues behind. As such, the NPs had to undergo a drying process at 120 °C to remove any remaining ethanol and moisture from their surfaces [27]. The synthesized Cu-doped ZnO NPs were kept in an airtight storage container until needed. This synthesis was repeated in triplicate to validate reproducibility, producing satisfactory results on all three batches using identical conditions. The synthesis yields of Cu-doped ZnO NPs was found to be 54% (mass per mass). To prepare ZnO NPs, we employed the identical process with the exception of using Cu(NO3)2·3H2O. The typical synthesis scheme for the preparation for Cu-doped ZnO NPs is depicted in Fig. 1. In this process, TSC acted as a reducing and stabilizing agent for Zn²⁺ and Cu²⁺ ions to be reduced to their metallic states (Zn⁰ and Cu⁰, respectively) to start the nucleation process. The microwave irradiation increased the molecular civic temperature rapidly and uniformly, which allowed for an accelerated state of super saturation and consequently instant nuclei of stable crystals were formed. The remaining time under exposure controlled the particle growth and provided Cu²⁺ ions to substitutional incorporate into the ZnO lattice that altered the electronic and optical properties of the nanoparticles, as compared to a pure ZnO lattice structure. Microwave-assisted heating provided a homogeneous energy distribution when compared to other conventional means of heating, reduced growth times, consistent and enhanced crystallinity, and a narrower distribution (size) of particles when compared to ZnO NPs created without microwave assistance [28]. Overall, as a generic synthetic protocol, the use of microwave-assisted heating in the fabrication of ZnO NPs and Cu-doped ZnO NPs offers a simplistic, reproducible, cost-effective, and controllable route to synthesized stable ZnO and Cu-doped ZnO NPs, specifically under mild-temperature conditions. Synthesis scheme for the preparation for Cu-doped ZnO NPs Antibacterial activity of Cu-doped ZnO nanoparticles The antimicrobial efficacy of ZnO NPs and Cu-doped ZnO NPs was examined in ethanol against the S. aureus, P. aeruginosa, E. coli, and C. albicans pathogens [29]. The bacterial strains were initially preserved in a lyophilized (freeze-dried) state and reactivated when required through overnight rehydration. These rehydrated cultures were then inoculated onto mannitol salt agar and nutrient agar plates to ensure proper selection and sustained growth. After incubating the plates at 37 °C for 24 h, a dense bacterial growth was obtained [30]. Once the cultures were well established, pristine ZnO and Cu-doped ZnO NPs were introduced to evaluate their antimicrobial potential. The inoculated plates were further incubated for 24 h following nanoparticle addition. Afterwards, the plates were carefully examined for inhibition zones or any visible reduction in bacterial growth, providing clear evidence of the bactericidal activity of Cu-doped ZnO NPs. Minimum inhibitory concentration (MIC) of synthesized Cu-doped ZnO NPs The minimum inhibitory concentration (MIC) of ZnO NPs and Cu-doped ZnO NPs was determined using the standard broth microdilution method, a widely accepted approach for assessing microbial sensitivity to antimicrobial agents. The MIC represents the lowest concentration of nanoparticles capable of preventing visible bacterial growth. To establish this, a two-fold serial dilution of the nanoparticles (25–250 µg/mL) was prepared in 96-well microplates. The bacterial suspension was adjusted to approximately 10⁸ CFU/mL, corresponding to the 0.5 McFarland standard, and then inoculated into Mueller–Hinton broth containing the different nanoparticle concentrations. Negative controls (broth without bacteria) and test wells with graded nanoparticle levels were incubated at 37 °C for 24 h to allow optimal growth conditions. The MIC was identified as the lowest nanoparticle concentration that completely prevented bacterial growth, indicated by the absence of turbidity in the wells. Turbidity measurements were taken before and after incubation to accurately compare the control and treated groups, ensuring precise determination of the MIC [10, 31]. The minimum bactericidal concentration (MBC) determination Following MIC evaluation, 60 µL from each tube that showed no visible microbial growth was streaked onto sterile BHI agar plates and incubated at 37 °C for 24 h. The minimum bactericidal concentration (MBC) was defined as the lowest concentration of Cu-doped ZnO NPs capable of eliminating ≥ 99.9% of the initial bacterial population. The MBC value was confirmed by comparing the agar plates before and after incubation to determine whether bacterial colonies were present or absent. Statistical analysis All antimicrobial measurements, including zone of inhibition, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC) assays, were carried out in triplicate (n = 3) to ensure the repeatability and reliability of the results. The obtained results are represented as mean ± standard deviation (SD). The zone of inhibition was separately measured for each of these triplicate cultures and averaged to avoid any bias. For comparison of pristine ZnO and Cu-doped ZnO NPs, one-way analysis of variance (ANOVA) was employed, and differences were considered statistically significant if p < 0.05. The use of standard deviation values in Table S5 provides a transparent view of the data variation and reliability of the experiments. Results and discussion Optical properties and band gap analysis UV-Vis spectral studies The optical response and band gap energies of the ZnO and Cu-doped ZnO NPs synthesized were analyzed using UV-Vis spectroscopy. For analysis, 0.01 g of each nanoparticle was sonicated in 10 mL of distilled water to achieve a uniformly suspended sample before the measurement. The spectra confirmed distinct maxima present at ~ 395 nm for ZnO NPs and ~ 400 nm for Cu-doped ZnO NPs (Fig. 2a). The red shift in absorption clearly suggests that Cu²⁺ has been successfully incorporated in the lattice of ZnO. Moreover, Cu-doped ZnO NPs displayed two bands, which can be ascribed to the concurrent presence of both intrinsic band-to-band transitions and impurity-induced states. The intrinsic band-to-band transition, observed in the near UV region, is the principal peak corresponding to the fundamental transition between the valence and conduction bands of ZnO NPs [32]. The primary estimate for the band gap (Eg) was first calculated using the equation E = hc/λ for calculating Eg. Where h is Planck’s constant (6.626 × 10− 34 J/s), c is the speed of light (2.99 × 108 m/s), and λ is the absorption edge. From the above calculations ZnO NPs have band gap energy of approximately 3.17 eV, and Cu-doped ZnO NPs had band gap energy of 3.10 eV, which confirms the narrowing of band gap as a result of Cu doping. To further establish the validity of these results, the classical Tauc relation (αhν = D(hν − Eg)n) was used. Where α is the absorption coefficient, hν is the photon energy, D is a material constant, and n is a number that corresponds to the nature of the electronic transition. Treating ZnO as a direct band gap semiconductor, a plot of (αhν)2 vs. hν was made (Fig. 2b). Using the linear region as a guide, the extrapolated value of Eg of 3.19 eV for Cu-doped ZnO, is in excellent agreement with the directly determined value of 3.10 eV. The close similarity between the two approaches indicates the validity of the optical measurements, and verifies that Cu incorporation very effectively tunes the electronic structure of ZnO [33]. More importantly, this band gap tuning verifies not only the success of doping, but also improves the suitability of Cu-doping ZnO NPs for optoelectronic, photocatalytic and energy related applications. a UV-visible spectra, b Tauc Plots, c Photoluminescence spectra, d FT-IR spectra, e Particle Size distribution (SEM), and f Dynamic light scattering of ZnO NPs, and Cu-doped ZnO NPs Photoluminescence analysis Photoluminescence (PL) spectroscopy enables one of the best tools to investigate the electronic structure and defect states of semiconductor nanomaterials. The PL spectra of ZnO and Cu-doped ZnO NPs under a 312 nm excitation (Fig. 2c) shows both near band edge and deep level emissions, characteristic properties of these NPs. For ZnO NPs, there is a sharp emission peak in the ultraviolet region at approximately 365 nm, while Cu-doped ZnO NPs had a peak at 375 nm, which is slightly red-shifted. Originating from the radiative recombination of free excitons at the band edges, emissions in this region demonstrate the high crystallinity and optical quality of the nanostructures. ZnO NPs exhibited a broad band centered around 525 nm, which can be assigned to defect-related states, such as oxygen vacancies and zinc interstitials. The incorporation of Cu into the ZnO NPs resulted in changes in the PL intensity and energy, which indicate the recombination of electrons and holes with a relatively slower rate due to the presence of defects such as oxygen vacancies, zinc interstitials, and Cu-induced impurity levels, affecting the antibacterial activity of Cu-doped ZnO NPs [34]. Moreover, a weaker emission of around 438 nm was also observed and suggested transitions associated with shallow donor levels associated with zinc interstitials. The large intensity of defect-mediated emissions from Cu-doped ZnO suggests that Cu-doping modified the defect landscape of ZnO, therefore, increasing the density of recombination centers and changing the optoelectronic properties [28]. Moreover, the blue shift observed in the optical absorption edge and the red shift observed in the photoluminescence emission upon Cu incorporation can be explained on the basis of different electronic transitions involved in these optical phenomena. The blue shift of the optical absorption edge is likely related to dopant-induced electronic reconstruction and possible Burstein-Moss-type effects, as changes in carrier concentration and Fermi level position are known to affect band-to-band transition energies. The red shift of the PL emission is likely related to defect-mediated radiative recombination processes. The Cu doping-induced defect states introduce localized impurity states and enhance intrinsic defect states like oxygen vacancies in the band gap of ZnO, resulting in lower-energy emission. The optical absorption is dominated by changes in the band structure, whereas defect states are involved in PL emission upon Cu doping. These changes could have not only tweaked the optical properties of ZnO, but may also have some relation to the observed antimicrobial properties of the nanoparticles as well. Functional groups analysis The FTIR spectroscopy was utilized to characterize the functional groups in the prepared ZnO and Cu-doped ZnO NPs. The FTIR spectra of both materials showed strong peaks at 470–480 cm⁻¹ that are characteristic of vibrations arising from metal–oxygen bonds (Fig. 2d). The 625–635 cm⁻¹ peak is associated with Zn/Cu–O stretching, confirming the incorporation of the Cu²⁺ into the ZnO lattice (Table S1) [32]. The incorporation of Cu²⁺ into the ZnO lattice is critical because it modifies the lattice structure, introducing structural defects and changing the bond network and can greatly improve the optical absorption and electronic conductivity of the nanoparticles. Dynamic light scattering (DLS) analysis Dynamic light scattering (DLS) technique was used in characterizing the prepared ZnO and Cu-doped NPs based on the hydrodynamic diameter. The results confirmed the size of ZnO and Cu-doped ZnO NPs (Fig. S1) with the average hydrodynamic diameter (Z-average) of 35.12 nm and 22.30 nm with a polydispersity index of 0.32 and 0.28, respectively. The prepared ZnO and Cu-doped ZnO NPs demonstrated a broadly defined size distribution with the most occurrence frequencies observed in the predominately dominant size peak at 30–35 nm and 20–25 nm, respectively (Fig. 2e) [26]. This indicates that most of the Cu-doped ZnO NPs population within the distribution is less than 25 nm in diameter because peak intensity is synonymous with the frequency of NPs occurrence within that size distribution. Thus, the formation of Cu-doped ZnO NPs through microwave-assisted approach indicates some sufficient control of nucleation and growth. Moreover, the observed moderate polydispersity of the prepared Cu-doped ZnO NPs is an indication of a fairly uniform particle population, which is critical to reproducible optical, electronic and biological properties [35]. The size distribution trends observed in DLS analysis is in general agreement with the confirmed SEM image size (Fig. 2f), thus fulfilling both the nanometric sized scale and structural integrity of the synthesized material. While most DLS and SEM particle sizes deviate to some extent, the overall agreement serves to confirm the inherent aspects of Cu-ZnO NPs synthesis collectively and establish the validity for biomedical and catalytic applications of Cu-ZnO particles with controlled size and functionality. Morphological and compositional analysis Surface morphology and structure of Cu-doped ZnO NPs was characterized by scanning electron microscopy (SEM) analysis. Since surface morphology directly impacts physiochemical behaviour and potential applications in catalysis, sensing, biomedical, and other areas, such characterization is crucial. The SEM micrographs presented in Fig. 3a–b show that the synthesized ZnO and Cu-doped NPs contributed to formations of a dense cluster morphology with irregular quasi-spherical shapes and significant agglomeration. This clustering response is normally associated with agglomerated characteristics created through high surface energy of nanoscale materials. However, along with the agglomerated morphologies for Cu-doped NPs, some areas appeared to show nanorod morphologies, which suggested the actual nanomaterial morphology could have been subjected to anisotropic growth, whilst Cu was incorporated as a dopant. The presence of spherical and rod-shape morphology indicates that Cu doping changes nucleation rates and may provide directionality in the crystallographic growth direction of ZnO. Doping with Cu in ZnO, altered nanomaterial morphology, suggested the successful incorporation of Cu in the ZnO lattice site, which also provided modification of the overall microstructural framework. Further, these structural changes are anticipated to improve functionality of the Cu-doped ZnO NPs, with improved reactivity and functional versatility as it is utilized in advanced technology. Moreover, the particle size analysis indicated a heterogeneous distribution, with diameters between about 15 and 25 nm for ZnO NPs and Cu-doped ZnO NPs, respectively (Fig. 2f). The FE-SEM (Fig. 3c–d) and EDX analysis (Fig. S2–S3) was performed to investigate the elemental composition of the prepared ZnO and Cu-doped NPs. The results are in good agreement with their elemental compositions, demonstrating the existence of Zn and O in ZnO NPs and Cu, Zn and O in Cu-doped ZnO NPs. Moreover, the EDX results validated the successful integration of an actual Cu content of around 5% in the Cu-doped ZnO NPs. a–b SEM images, and c–d FE-SEM elemental maps for ZnO NPs and Cu-doped ZnO NPs Structural analysis The structural properties of Cu-doped ZnO NPs were examined using X-ray diffraction (XRD). The XRD pattern for ZnO and Cu-doped ZnO NPs (Fig. 4a) showed well resolved and distinct diffraction peaks characteristic of crystalline materials. The reflections represented here are closely aligned to the hexagonal wurtzite phase of ZnO, meaning that even with the addition of Cu, the fundamental crystal symmetry of ZnO is still preserved. The diffraction peaks recorded at 2θ of 31.69°, 34.36°, 36.17°, 47.49°, 56.55°, 62.78°, 66.28°, 67.88°, and 68.96° can be indexed to (100), (002), (101), (102), (110), (103), (200), (112), and (201) crystallographic planes respectively, based on the standard ZnO phase. Table S2 illustrates the XRD peaks position along with miller index for both the pristine ZnO and Cu-doped ZnO NPs. Doping with Cu introduces slight changes in the structure and often leads to more noticeable changes without changing the wurtzite structure. Moreover, the enhanced shoulder between ~ 10° and ~ 40° is attributed to nanoscale crystallinity, defect-induced lattice distortion due to the addition of Cu instead of amorphous impurity-type phases. The changes can be observed with changes in lattice constants, interplanar spacing, micro-strain and defect density, that will determine the electronic and optical properties of NPs [36]. The incorporation of Cu2+ into the ZnO lattice induces distortions mostly due to the higher ionic radius of Cu2+ in comparison to the lower ionic radius of Zn2+, resulting in significant alterations in lattice characteristics. a XRD pattern of ZnO NPs, and Cu-doped ZnO NPs. XPS scan for Zn2p of b ZnO NPs, and c Cu-doped ZnO NPs. XPS scan for d Cu2p, and e O1s for Cu-doped ZnO NPs. f XPS survey for Cu-doped ZnO NPs The crystallite size (D) was calculated using the Debye–Scherrer equation (Eq. 1). where λ is the wavelength of Cu Kα radiation (1.5406 Å), β is the full width at half maximum (FWHM) of the most intense diffraction peak, and θ is the Bragg diffraction angle. The lattice parameters (a and c) for the hexagonal wurtzite ZnO structure were computed using Eq. 2. where (hkl) are Miller indices and d is the interplanar spacing derived from Bragg’s law (Eq. 3). The percentage crystallinity was estimated by comparing the integrated area of crystalline peaks with the total diffraction pattern area using the (Eq. 4). The calculated structural parameters from XRD analysis confirmed the formation of a hexagonal wurtzite crystal structure for both pristine ZnO and Cu-doped ZnO NPs. The crystallite size determined using the Debye–Scherrer equation was found to be 54 nm for ZnO NPs and reduced to 35 nm after Cu doping, indicating defect-driven crystal growth suppression. The lattice constants were calculated using the indexed diffraction peaks and Bragg’s law, yielding lattice parameter values of a = 3.258 Å, c = 5.201 Å for ZnO and a = 3.247 Å, c = 5.035 Å for Cu-doped ZnO NPs. A slight contraction/expansion in lattice parameters after doping suggests substitutional incorporation of Cu²⁺ (ionic radius 0.57 Å) in the Zn²⁺ (0.60 Å) lattice sites. The interplanar spacing (d) values, calculated for major reflections, showed minor shifts toward higher/lower 2θ values, further supporting lattice distortion induced by Cu incorporation. The extent of crystallinity was found to increase from 65% for pristine ZnO to 78% for Cu-doped ZnO, indicating improved long-range ordering of ZnO crystals after Cu doping. Improved crystallinity can be attributed to improved nucleation and crystal growth rates during microwave treatment, where heating is more uniform to improve the lattice ordering. At the same time, Cu doping may create lattice distortions and defects, affecting its electrical and optical properties without necessarily affecting its long-range ordering. These findings corroborate the successful structural modification of ZnO NPs upon Cu incorporation. Surface elemental composition and chemical states analysis The XPS was conducted to study the surface chemistry, elemental distribution, and oxidation states of the pristine ZnO and the Cu-doped ZnO NPs. The survey scans and high-resolution spectra identified the expected elemental signatures, demonstrating Cu had been introduced into the ZnO structure. The Zn 2p spectrum for both the ZnO NPs and Cu-doped ZnO NPs showed strong peak signatures corresponding to the Zn 2p3/2 and Zn 2p1/2 states at binding energies of approximately 1022 eV and 1045 eV, respectively (Fig. 4b–c). These results correspond well with Zn²⁺ species associated with the ZnO wurtzite lattice, suggesting the primary oxidation state remained unchanged and that the crystallographic structure of the ZnO was not compromised upon Cu-doping. In the Cu 2p section (Fig. 4d), prominent peaks around 933.3 eV and 954.2 eV display fast satellite features at higher energies that confirm the presence of Cu²⁺ ions, excluding the presence of metallic copper or Cu⁺. These spectral fingerprints provide solid support for substitutional doping of divalent Cu into the ZnO lattice. The O 1s spectrum (Fig. 4e) also showed a peak around ~ 531.9 eV, with slight asymmetry suggesting a contribution from both lattice oxygen species and surface-bound species, e.g., OH or adsorbed oxygen [37]. The oxygen features are of special interest due to their influence on photocatalytic reactivity and antimicrobial potential. Further, the XPS survey showed the signals corresponding to each element present in the Cu-doped NPs, indicating successful incorporation of Cu²⁺ ions into the ZnO lattice (Fig. 4f). Computational studies The electronic properties of Cu-doped ZnO NPs can be satisfactorily characterized with band structure and density of states (DOS) calculations. The results indicated that the Cu dopant improved the DOS across the Fermi level in the electronic structure, thereby likely increasing the optical absorption of Cu-doped ZnO NPs in the visible region. The calculated band gap of 3.05 eV shows a slight decrease in band gap from the pristine gap of ZnO (3.17 eV) [22, 38]. This suggests that Cu-doping can be utilized to modify the electronic structure of ZnO. The highest occupied molecular orbital (HOMO) energy can be correlated to the valence band, while the lowest unoccupied molecular orbital (LUMO) more closely aligns with the conduction band. The implementations of the band gap values observed from the calculations are consistent with experimental observations. Figure 5a–b showed the optimized geometry of ZnO and Cu-doped ZnO NPs. The DOS and band structure of ZnO and Cu-doped ZnO NPs are shown in Fig. 5c–d and Fig. 5e–f, affirming the electronic changes induced by Cu doping. Further, to correlate the biological properties of the prepared NPs with their electronic properties, quantum chemical descriptors, including ionization energy (IE), electron affinity (EA), hardness, global softness, electrophilicity, etc., were also computed, as shown in Table S3. Top- and Side-views of optimized geometry of a ZnO NPs, b Cu-doped ZnO NPs. Density of states of c ZnO NPs, d Cu-doped ZnO NPs. Band structure of e ZnO NPs, f Cu-doped ZnO NPs The enhanced antimicrobial activity observed in Cu-doped ZnO NPs compared to pristine ZnO can be rationalized based on their lower band gap energy and corresponding quantum chemical descriptors. The reduction in the band gap facilitates excitation of electrons from the valence band to the conduction band, thereby enhancing charge carrier mobility and increasing the generation of ROS, which are primarily responsible for microbial inactivation. Additionally, the Cu-doped ZnO NPs exhibit a lower HOMO–LUMO energy gap, indicating improved electronic polarizability and reactivity. The decrease in global hardness (η) and increase in global softness (S) suggest that the doped system is more chemically reactive and responds more readily to interactions with biological macromolecules. Furthermore, the higher electron affinity (EA) of Cu-doped ZnO NPs favours electron acceptance from microbial cell components, disrupting cellular metabolism and membrane integrity. Collectively, these electronic modifications induced by Cu doping lead to improved charge transfer properties and enhanced ROS generation efficiency, ultimately resulting in superior antimicrobial performance compared to undoped ZnO NPs. Antimicrobial properties Antibacterial effectiveness of ZnO NPs (Fig. 6a–b) and Cu-doped ZnO NPs (Fig. 6d–e) were systematically studied against the pathogenic bacteria, including S. aureus, P. aeruginosa, and E. coli. Cu-doped ZnO NPs samples inhibited bacterial growth more effectively than control sample and ZnO NPs, as indicated by inhibition zones of up to 22.3 mm and 23.5 mm for S. aureus and E. coli, respectively. Besides, antifungal activity of ZnO NPs (Fig. 6c) and Cu-doped ZnO NPs (Fig. 6f) was assessed against C. albicans, affirming their potential as antifungal agents. The results indicated that both the ZnO NPs and Cu-doped ZnO NPs are capable to exhibit zone of inhibition values of 20.5 mm and 23.5 mm, respectively. This zone of inhibition against the pathogens displayed by Cu-doped ZnO NPs is remarkably higher than displayed by various transition metal–doped ZnO nanostructures. For example, Fe-doped ZnO NPs prepared through plant-mediated processes often show a moderate antibacterial activity with zone of inhibition values between 11 and 20 mm. Cu-doped ZnO NPs specifically when combined with polymers have an enhanced level of antibacterial activity against ‘Gram positive’ type bacteria but do not exhibit consistent broad-spectrum activity across all bacteria types. Ag-doped ZnO nanostructures generally demonstrate high antimicrobial activity (Table S4). Antimicrobial activity of ZnO NPs against a S. aureus, b E. coli, and c C. albicans. Antimicrobial activity of Cu-doped ZnO NPs against a S. aureus, b E. coli, and c C. albicans However, these materials typically need higher concentrations of Ag for effective use and there is potential for cytotoxicity, cost and long-term environmental issues arising from these nanostructures. These comparative results indicate that microwave-assisted prepared Cu-doped ZnO NPs maybe used as a new class of antimicrobial agents equivalent to the conventional antimicrobial agent Gentamycin, which could provide infection prevention from both bacteria and fungi caused from drug resistant strains [43]. High level of zone of inhibition of Cu-doped ZnO NPs against various pathogens (Fig. 7) supports their potential towards antimicrobial activity and can be served as environmentally safe material for the biomedical application to reduce microbial infection incidence and drug resistance [43]. An overview of the antimicrobial data obtained using Cu-doped-ZnO versus Gentamycin against several common pathogens is presented in Table S5. Moreover, antimicrobial potential of prepared Cu-doped ZnO NPs against S. aureus, P. aeruginosa, E. coli, and C. albicans pathogens was also evaluated using MIC and MBC assays. Among the tested microorganisms, S. aureus showed the highest sensitivity with a clear inhibition zone of 23 ± 0.61 mm. The Cu-doped ZnO NPs showed excellent antibacterial activity, especially at a concentration of 25 µg/mL. The MIC values ranged from 25 to 250 µg/mL, which shows the effectiveness of the NPs as an antimicrobial agent. The MBC values for the tested microorganisms also showed the bactericidal effect of the NPs, especially for S. aureus. The inhibition zones for E. coli and C. albicans at 500 µg/mL and 100 µg/mL, respectively, were found to be lower for the NPs. The MIC values for the standard antibiotic, Gentamycin, for all the tested microorganisms were found to be as shown in Table S5. According to the criteria, the MBC/MIC ratio ≤ 2 indicates a bactericidal effect, while the ratio ≥ 4 indicates a bacteriostatic effect [13]. The MBC/MIC ratio was determined to be ≤ 2 for all the microorganisms under investigation, which clearly indicates the bactericidal nature of the ZnO NPs doped with Cu. Table S5 shows the data used in the MIC and MBC analysis to determine the antimicrobial activity of the Cu-doped ZnO NPs and Gentamycin. Graphical representation of antimicrobial activity of the ZnO and Cu-doped ZnO NPs From the mechanistic perspective, optical characterization results indicated that there was a measurable change in the band gap energy from 3.17 eV for pure ZnO to 3.05 eV for Cu-doped ZnO. Furthermore, photoluminescence analysis indicated that there were enhanced features in the visible region related to defect states like oxygen vacancies. These findings have further strengthened the idea that the incorporation of Cu has indeed affected the electronic structure of ZnO [39]. Although the quantification of ROS has not been conducted in this study, it has been reported that changes in the band gap and defect states can be associated with the charge separation properties in semiconductor materials. The improvement in the antimicrobial properties of Cu-doped ZnO NPs can thus be associated with the changes in the electronic structure that can potentially influence the redox properties. However, this interpretation is based on indirect optical and computational evidence rather than direct ROS measurements. On the other hand, surface morphology and crystallite size further contribute to the observed biological behaviour. SEM and DLS analysis indicated the presence of nanoparticles with reduced crystallite size after doping with Cu, which would be advantageous with respect to the contact area with the microbial membranes. Therefore, a multiple pathway inhibition mechanism for ZnO and Cu-doped ZnO NPs against S. aureus, P. aeruginosa, E. coli, and C. albicans is proposed. The antimicrobial activity of the ZnO and Cu-doped ZnO NPs can be explained by several different processes. The modified electronic structure of the doped ZnO NPs suggests that there will be a higher redox potential at the nanoparticle/microbe interface, improving antimicrobial activity of Cu-doped ZnO NPs. Moreover, the release of Zn²⁺ and Cu²⁺ can play an important role in the antimicrobial properties of the ZnO and Cu-doped ZnO NPs. The Cu²⁺ can bind to the thiol group of proteins. In addition, Cu²⁺ can interfere with enzymatic processes and can inhibit cellular respiration. On the other hand, the interaction of the nanoparticle with the microbial membrane can cause destabilization of the membrane [40, 41]. The nanoscale dimensions of the ZnO and Cu-doped ZnO NPs can cause destabilization of the microbial membrane. The results of this study clearly indicate that doping with Cu changes the structure of the ZnO NPs in a manner that improves its bactericidal and antifungal properties. Conclusion This study has successfully engineered Cu-doped ZnO nanoparticles via a microwave-assisted method. The structural, optical, and in vitro antibacterial properties have been extensively investigated. The retention of the hexagonal wurtzite structure of ZnO without secondary phases in the doped ZnO sample was verified by the XRD analysis. Compositional analysis verified that Cu was doped into the ZnO structure. The optical studies have shown that Cu doping affects the absorption edge as well as defect emissions of ZnO NPs. Further, in vitro antibacterial properties were assessed against S. aureus, P. aeruginosa, E. coli, and C. albicans by measuring the zone of inhibition, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC). The Cu-doped ZnO nanoparticles exhibited superior antibacterial and antifungal efficacy relative to pristine ZnO, with established bactericidal properties (MBC/MIC ≤ 2). It is important to note that this study is limited to in vitro antimicrobial evaluation. Cytotoxicity assessment, biocompatibility analysis, quantitative ROS measurements, and in vivo validation were not conducted and remain necessary for future investigations to determine clinical or biomedical applicability. Supplementary Information Below is the link to the electronic supplementary material Supplementary Material 1 Acknowledgements The authors would like to extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through Waed Program (W25-10). Author contributions S.S.A. and A.K. write the pre-draft of the manuscript. M.U., K.B.A., T.A.K., and A.B.I. provided the comments. A.M.A supervised the project throughout. Funding This work is funded by Deanship of Scientific Research at King Saud University through Waed Program (W25-10). Data availability The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethical approval This study does not involve human participants or animal experiments; therefore, ethical approval was not required. Consent to participate Not applicable, as the study did not involve human participants. Consent to publish Not applicable, as no individual person’s data or identifiable information is included in this manuscript. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.